STROKE IN 2013 Disappointments and advances in acute stroke intervention

Clinical trials in stroke intervention during the past year have yielded contrasting results. Endovascular therapies and procedures to reduce stroke risk caused by patent foramen ovale have failed to demonstrate superiority over standard medical treatments. By contrast, a trial of neuroprotection-traditionally thought to be ineffective in humans-offers hope.